{
    "clinical_study": {
        "@rank": "53768", 
        "acronym": "DCS", 
        "arm_group": [
            {
                "arm_group_label": "Telemedical Coaching", 
                "arm_group_type": "Experimental", 
                "description": "Patients will receive  telemedical devices i.e. for the measurement of blood glucose, weight and physical activity. These devices will transfer the data to a data collector with a SIM card which sends the data to a data portal, which can be monitored by the participant and the coach. Health coaches which will have close phone contact to patients, supporting them to reduce weight and increase physical activity. In the first 12 weeks, patients will follow a formula diet (Almased) to achieve an initial weight reduction."
            }, 
            {
                "arm_group_label": "Telemedicine", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients will receive  telemedical devices i.e. for the measurement of blood glucose, weight and physical activity. These devices will transfer the data to a data collector with a SIM card which sends the data to a data portal which can be monitored by the participant."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to compare the effect of telemedical coaching versus telemedical\n      control on HbA1c, weight, BMI, blood pressure, blood lipids, medication, nutrition, physical\n      activity and quality of life in type 2 diabetes patients with poor glycaemic control."
        }, 
        "brief_title": "Diabetes Coaching Study", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  type 2 diabetes mellitus\n\n          -  hemoglobin A1c (HbA1c) >7.5%\n\n          -  at leat two different antidiabetic drugs\n\n          -  body mass index >27kg/m2\n\n        Exclusion Criteria:\n\n          -  acute infections\n\n          -  diagnosed chronic diseases other than type 2 diabetes and hypertension, e.g. cancer,\n             chronic obstructive pulmonary disease (COPD), asthma, dementia, chronic gut diseases,\n             psychoses, liver cirrhosis, (macro-) nephropathy, kidney insufficiency with\n             glomerular filtration rate (eGFR) < 30ml / min / 1.73 m2\n\n          -  acute chemotherapy or chronic cortisol treatment\n\n          -  smoking cessation for less than 3 months and or planned smoking cessation during\n             study\n\n          -  known intolerance of any ingredient of Almased (especially soy protein)\n\n          -  pregnancy or breast feeding, lack of contraception (women)\n\n          -  other study participation in the last 6 months prior to study start"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "79 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02066831", 
            "org_study_id": "DCS"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Telemedical Coaching", 
                    "Telemedicine"
                ], 
                "intervention_name": "Telemedical coaching", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": "Telemedical Coaching", 
                "intervention_name": "Telemedicine", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 17, 2014", 
        "link": {
            "description": "Homepage", 
            "url": "http://www.vkkd-kliniken.de"
        }, 
        "location": {
            "contact": {
                "email": "martin@wdgz.de", 
                "last_name": "Stephan Martin, MD", 
                "phone": "+49-(0)211-5660360", 
                "phone_ext": "70"
            }, 
            "contact_backup": {
                "email": "kerstin.kempf@wdgz.de", 
                "last_name": "Kerstin Kempf, PhD", 
                "phone": "+49-(0)211-5660360", 
                "phone_ext": "16"
            }, 
            "facility": {
                "address": {
                    "city": "D\u00fcsseldorf", 
                    "country": "Germany", 
                    "zip": "40591"
                }, 
                "name": "West-German Center of Diabetes and Health"
            }, 
            "investigator": {
                "last_name": "Stephan Martin, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Diabetes Coaching Study", 
        "overall_contact": {
            "email": "martin@wdgz.de", 
            "last_name": "Stephan Martin, MD", 
            "phone": "+49-(0)211-5660360", 
            "phone_ext": "70"
        }, 
        "overall_contact_backup": {
            "email": "kerstin.kempf@wdgz.de", 
            "last_name": "Kerstin Kempf, PhD", 
            "phone": "+49-(0)211-5660360", 
            "phone_ext": "16"
        }, 
        "overall_official": {
            "affiliation": "West German Center of Diabetes and Health", 
            "last_name": "Stephan Martin, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Ethics Commission", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Difference in HbA1c (at end of study vs. baseline) between the groups", 
            "measure": "HbA1c", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02066831"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Difference in weight (at end of study vs. baseline) between the groups", 
                "measure": "weight", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Difference in antidiabetic medication (at end of study vs. baseline) between the groups", 
                "measure": "antidiabetic medication", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Difference in cardiovascular risk parameters (i.e. blood pressure, blood lipids) (at end of study vs. baseline) between the groups", 
                "measure": "Cardiovascular risk parameters (blood pressure, blood lipids)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Difference in physical activity (at end of study vs. baseline) between the groups", 
                "measure": "physical activity (step count)", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Difference in nutrition (at end of study vs. baseline) between the groups", 
                "measure": "nutrition", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Difference in quality of life (at end of study vs. baseline) between the groups", 
                "measure": "quality of life", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "West German Center of Diabetes and Health", 
        "sponsors": {
            "collaborator": {
                "agency": "Deutsches Institut f\u00fcr Telemedizin und Gesundheitsf\u00f6rderung (DITG)", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "West German Center of Diabetes and Health", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}